Pharmala Biotech Holdings Inc. (MDMA.CN)
CAD 0.16
(-6.06%)
CAD 0.16
(-6.06%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1.21 Million CAD | 14.67% |
| 2022 | 1.06 Million CAD | -57.7% |
| 2021 | 2.5 Million CAD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 297.2 Thousand CAD | 17.19% |
| 2024 Q1 | 253.6 Thousand CAD | -6.68% |
| 2024 Q3 | 271.95 Thousand CAD | -8.5% |
| 2023 Q2 | 311.22 Thousand CAD | 7.88% |
| 2023 Q1 | 288.5 Thousand CAD | 45.3% |
| 2023 Q3 | 338.74 Thousand CAD | 8.84% |
| 2023 FY | 1.21 Million CAD | 14.67% |
| 2023 Q4 | 271.76 Thousand CAD | -19.77% |
| 2022 Q2 | 285.33 Thousand CAD | -5.74% |
| 2022 Q1 | 302.72 Thousand CAD | 0.0% |
| 2022 Q3 | 274.75 Thousand CAD | -3.71% |
| 2022 FY | 1.06 Million CAD | -57.7% |
| 2022 Q4 | 198.56 Thousand CAD | -27.73% |
| 2021 Q3 | 2.31 Million CAD | 0.0% |
| 2021 FY | 2.5 Million CAD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Algernon Pharmaceuticals Inc. | 5.19 Million CAD | 76.557% |
| Asep Medical Holdings Inc | 7.74 Million CAD | 84.281% |
| BetterLife Pharma Inc. | 3.24 Million CAD | 62.44% |
| BioVaxys Technology Corp. | 2.4 Million CAD | 49.345% |
| ChitogenX Inc. | 2.83 Million CAD | 56.995% |
| Rapid Dose Therapeutics Corp. | 4.2 Million CAD | 71.081% |
| Defence Therapeutics Inc. | 12.65 Million CAD | 90.383% |
| Entheon Biomedical Corp. | 564.31 Thousand CAD | -115.668% |
| Gemina Laboratories Ltd. | 5.08 Million CAD | 76.07% |
| Glow Lifetech Corp. | 25.71 Thousand CAD | -4632.837% |
| Lexston Life Sciences Corp. | 674.71 Thousand CAD | -80.379% |
| Doseology Sciences Inc. | 72.08 Thousand CAD | -1588.306% |
| MYND Life Sciences Inc. | 1.47 Million CAD | 17.476% |
| Nova Mentis Life Science Corp. | 1.2 Million CAD | -1.227% |
| PharmaTher Holdings Ltd. | 3.04 Million CAD | 60.019% |
| PreveCeutical Medical Inc. | 963.12 Thousand CAD | -26.365% |
| Telescope Innovations Corp. | 6.35 Million CAD | 80.841% |